Atria Wealth Solutions, Inc.
- SEC CIK
- 0001927543
- Latest filing
- Jul 25, 2025
TEVA holding history
Teva Pharmaceutical Industries Ltd in every 13F filed by Atria Wealth Solutions, Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
TEVA overviewAll 13F holders of TEVAFull Q2 2025 holdings
- Shares (Q3 2024)
- 0
- Sold out in Q3 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 9
- Since Q1 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2024 | 0 | $0 | 0.0% | −16,796−100.0% | Sold out | Holders |
| Q2 2024 | 16,796 | $272.9K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2024 | 16,796 | $237.0K | <0.1% | +13+0.1% | Added | Holders |
| Q4 2023 | 16,783 | $175.2K | <0.1% | −1,000−5.6% | Reduced | Holders |
| Q3 2023 | 17,783 | $181.4K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2023 | 17,783 | $133.9K | <0.1% | −96−0.5% | Reduced | Holders |
| Q1 2023 | 17,879 | $158.2K | <0.1% | −26−0.1% | Reduced | Holders |
| Q4 2022 | 17,905 | $163.3K | <0.1% | −10,854−37.7% | Reduced | Holders |
| Q3 2022 | 28,759 | $232.1K | <0.1% | +28,759 | New | Holders |
| Q2 2022 | 0 | $0 | 0.0% | −30,379−100.0% | Sold out | Holders |
| Q1 2022 | 30,379 | $285.0K | <0.1% | – | No prior filing | Holders |